trending Market Intelligence /marketintelligence/en/news-insights/trending/Xvgs_u1eACCMIXtqLuc_Xg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Magnesium Development secures investment from Cultivate(MD) fund

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible


Magnesium Development secures investment from Cultivate(MD) fund

Cultivate(MD) LLC, through its early-stage healthcare fund Cultivate (MD) Capital Fund II LP, invested an undisclosed sum in Magnesium Development Co. LLC.

The Missoula, Mont-based target company provides a magnesium alloy technology for orthopedic applications, including interference screws for anterior cruciate ligament repair, sports medicine anchors, plates, screws and wires addressing foot and ankle procedures, as well as for trauma applications.

Magnesium Development CEO Rob Ball said in a release that his company aims to use the funding to help advance the alloy technology for human orthopedic use later in 2019.

Cultivate(MD) is a venture capital unit of biotechnology-focused Genesis Innovation Group LLC.